Diagnostic Value of a Chimeric TSH Receptor (Mc4)-Based Bioassay for Graves' Disease
![]() |
Lee, Ji-In
(Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Jang, Hye-Won (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Soo-Kyoung (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Choi, Joon-Young (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Ji-Young (Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Hur, Kyu-Yeon (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Jae-Hyeon (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Min, Yong-Ki (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Chung, Jae-Hoon (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Sun-Wook (Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Brent GA. Clinical practice: Graves' disease. N Engl J Med 2008;358:2594-2605. DOI ScienceOn |
2 | Ajjan RA, Weetman AP. Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab 2008;4:461-468. DOI ScienceOn |
3 | Smith BR, Bolton J, Young S, et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 2004;14:830-835. |
4 | Villalta D, Orunesu E, Tozzoli R, et al. Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers. J Clin Pathol 2004;57:378-382. DOI ScienceOn |
5 | Ochi Y, Kajita Y, Wu L, Iidaka M, Nagayama Y. Augmentative effect of polyethylene glycol, polyvinyl alcohol and dextran on thyroid-stimulating antibody stimulated cAMP production in FRTL-5 cells and CHO cells expressing human TSH receptor. Horm Res 2000;53:20-25. |
6 | Preissner CM, Wolhuter PJ, Sistrunk JW, Homburger HA, Morris JC 3rd. Comparison of thyrotropin-receptor antibodies measured by four commercially available methods with a bioassay that uses Fisher rat thyroid cells. Clin Chem 2003;49:1402-1404. DOI ScienceOn |
7 | Hovens GC, Buiting AM, Karperien M, et al. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease. Clin Endocrinol (Oxf) 2006;64:429-435. |
8 | Tahara K, Ban T, Minegishi T, Kohn LD. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun 1991;179:70-77. DOI ScienceOn |
9 | Lytton SD, Ponto KA, Kanitz M, Matheis N, Kohn LD, Kahaly GJ. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J Clin Endocrinol Metab 2010;95:2123-2131. DOI ScienceOn |
10 | Kamijo K, Murayama H, Uzu T, Togashi K, Kahaly GJ. A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves' disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells. Thyroid 2010;20:851-856. DOI ScienceOn |
11 | Rakover Y, Sadeh O, Sobel E, Shneyour A, Kraiem Z. A case of transient hypothyroidism: sequential serum measurements of autoantibodies inhibiting thyrotropin-stimulated thyroid cAMP production in a neonate. Acta Endocrinol (Copenh) 1990;123:118-122. |
12 | Ueda Y, Sugawa H, Akamizu T, et al. Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition. Eur J Endocrinol 1995;132:62-68. DOI ScienceOn |
13 | Kim WB, Chung HK, Park YJ, Park DJ, Lee HK, Cho BY. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies. Korean J Intern Med 2001;16:187-200. |
14 | Watson PF, Ajjan RA, Phipps J, Metcalfe R, Weetman AP. A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease. Clin Endocrinol (Oxf) 1998;49:577-581. DOI ScienceOn |
15 | Evans C, Morgenthaler NG, Lee S, et al. Development of a luminescent bioassay for thyroid stimulating antibodies. J Clin Endocrinol Metab 1999;84:374-377. DOI ScienceOn |
16 | Grasso YZ, Kim MR, Faiman C, Kohn LD, Tahara K, Gupta MK. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors. Thyroid 1999;9:531-537. DOI ScienceOn |
17 | Flynn A, Hirvonen T, Mensink GB, et al. Intake of selected nutrients from foods, from fortification and from supplements in various European countries. Food Nutr Res 2009;53. DOI: 10.3402/fnr.v53i0.2038. |
18 | Kim JY, Kim KR. Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases. Yonsei Med J 2000;41:22-28. |
19 | Kim JY, Moon SJ, Kim KR, Sohn CY, Oh JJ. Dietary iodine intake and urinary iodine excretion in normal Korean adults. Yonsei Med J 1998;39:355-362. |
![]() |